Cishe abantu abayizigidi ezingu-1.5 e-United States banesifo samathambo.
rheumatoid arthritis, noma i-RA, yisifo esingelapheki, esizimele esibonakala ngobuhlungu nokuvuvukala kwamalunga. Nge-RA, amasosha omzimba, avikela inhlalakahle yethu ngokuhlasela izinto zangaphandle njengama-bacteria namagciwane, ahlasela amalunga ngephutha. I-Rheumatoid arthritis ivame ukuphatha amalunga ezandla, izinyawo, izihlakala, izindololwane, amadolo namaqakala. Ochwepheshe abaningi bezempilo batusa ukuhlonzwa kusenesikhathi kanye nokwelashwa kwe-RA.
abstract
I-arthritis ye-Rheumatoid yisifo samathambo esivame ukutholakala kakhulu. Abesifazane, ababhemayo, nalabo abanomlando womndeni walesi sifo bavame ukuthinteka. Imibandela yokuxilongwa ihlanganisa ukuba okungenani nelunga elilodwa elinokuvuvukala okuqondile okungachazwanga esinye isifo. Amathuba okuxilongwa kwe-arthritis ye-rheumatoid ayanda ngenani lamalunga amancane ahilelekile. Esigulini esinesifo samathambo esivuvukalayo, ukuba khona kwesici se-rheumatoid noma i-anti-citrullinated protein antibody, noma izinga eliphezulu le-C-reactive protein noma izinga le-erythrocyte sedimentation liphakamisa ukuxilongwa kwe-arthritis ye-rheumatoid. Ukuhlolwa kwaselabhorethri kokuqala kufanele futhi kufake inani legazi eliphelele elinomehluko kanye nokuhlolwa kokusebenza kwezinso nesibindi. Iziguli ezithatha ama-biologic agents kufanele zihlolwe i-hepatitis B, i-hepatitis C, nesifo sofuba. Ukuxilongwa kwangaphambi kwesikhathi kwe-arthritis ye-rheumatoid kuvumela ukwelashwa kwangaphambili ngama-antirheumatic agents okuguqula izifo. Inhlanganisela yemithi ivame ukusetshenziselwa ukulawula lesi sifo. I-Methotrexate imvamisa umuthi womugqa wokuqala we-rheumatoid arthritis. Ama-biologic agents, afana ne-tumor necrosis factor inhibitors, ngokuvamile athathwa njengama-ejenti omugqa wesibili noma angangezwa ukuze athole ukwelashwa okukabili. Imigomo yokwelashwa ihlanganisa ukunciphisa ubuhlungu obuhlangene nokuvuvukala, ukuvimbela ukulimala kwe-radiographic nokukhubazeka okubonakalayo, nokuqhubeka komsebenzi kanye nemisebenzi yomuntu siqu. Ukushintshwa okuhlangene kuboniswa ezigulini ezinokulimala okukhulu kwamalunga azo izimpawu zazo zingalawulwa kahle ukuphathwa kwezokwelapha. (Am Fam Physician. 2011;84(11):1245-1252. Copyright � 2011 American Academy of Family Physicians.)
I-arthritis ye-Rheumatoid (RA) yisifo samathambo esivame kakhulu esivuvukalayo, esinobukhulu bokuphila kuze kufike kumaphesenti angu-1 emhlabeni wonke. Ukuqala kwe-1 kungenzeka kunoma yikuphi ubudala, kodwa ukuphakama phakathi kweminyaka engu-30 no-50. 2 Ukukhubazeka kuvamile futhi kubalulekile. Eqenjini elikhulu lase-US, amaphesenti angama-35 eziguli ezine-RA abenokukhubazeka emsebenzini ngemva kweminyaka eyi-10
I-Etiology kanye ne-Pathophysiology
Njengezifo eziningi ze-autoimmune, i-etiology ye-RA i-multifactorial. Ukuthinteka kwezakhi zofuzo kubonakala ekuhlanganiseni komndeni kanye nezifundo zamawele e-monozygotic, ngamaphesenti angu-50 wengozi ye-RA ebangelwa izici zofuzo. Izifundo ze-4 Genome-wide association ziye zathola amasignesha engeziwe ofuzo okwandisa ingozi ye-RA nezinye izifo ezizimele, kuhlanganise ne-STAT45 gene kanye ne-CD1 locus.6,7 Ukubhema kuyimbangela enkulu yemvelo ye-RA, ikakhulukazi kulabo abane-genetic predisposition.4 Nakuba izifo ingase ivule impendulo ye-autoimmune, ayikho i-pathogen ethile eye yafakazelwa ukuthi ibangele i-RA.40 RA ibonakala ngezindlela zokuvuvukala eziholela ekwandeni kwamaseli e-synovial emalungeni. Ukwakheka kwe-pannus okulandelayo kungase kuholele ekubhujisweni koqwanga kanye nokuguguleka kwamathambo. Ukukhiqizwa ngokweqile kwama-cytokines ane-pro-inflammatory, kuhlanganise ne-tumor necrosis factor (TNF) ne-interleukin-5, kuqhuba inqubo ebhubhisayo.8
Izingozi Zezingozi
Iminyaka yobudala, umlando womndeni wesifo, kanye nobulili besifazane kuhlotshaniswa nengozi eyengeziwe ye-RA, nakuba ukuhlukana kobulili kungabonakali kakhulu ezigulini ezindala.1 Kokubili ukubhema ugwayi wamanje nangaphambilini kwandisa ingozi ye-RA (ingozi ehlobene [RR]) = 1.4, kuze kufike ku-2.2 kubantu ababhemayo abaneminyaka engaphezu kwengu-40).11 Ukukhulelwa ngokuvamile kubangela ukukhululwa kwe-RA, cishe ngenxa yokubekezelelana kwe-immunologic.12 Ukulingana kungase kube nomthelela ohlala njalo; I-RA mancane amathuba okuthi itholwe kwabesifazane abaqhanyelwe kunakwabesifazane abangenalutho (RR = 0.61).13,14 Ukuncelisa ibele kunciphisa ingozi ye-RA (RR = 0.5 kwabesifazane abancelisa okungenani izinyanga ezingu-24), kanti ukuya esikhathini ngaphambi kwesikhathi�(RR = 1.3 kulabo abaqala ukuya esikhathini lapho beneminyaka engu-10 ubudala noma ngaphansi) kanye nezikhathi zokuya esikhathini ezingavamile kakhulu (RR = 1.5) zandisa ingozi.14 Ukusetshenziswa kwamaphilisi okuvimbela inzalo ngomlomo noma i-vitamin E ayithinti ingozi ye-RA.15
Sifo
Isethulo Esijwayelekile
Iziguli ezine-RA ngokuvamile ziba nobuhlungu nokuqina emalungeni amaningi. Izihlakala, amalunga e-interphalangeal asondelene, namajoyinti e-metacarpophalangeal avame ukubandakanyeka. Ukuqina kwasekuseni okuhlala isikhathi esingaphezu kwehora elilodwa kubonisa i-etiology yokuvuvukala. Ukuvuvukala kwe-Boggy ngenxa ye-synovitis kungase kubonakale (Umfanekiso 1), noma ukuqina kwe-synovial okucashile kungase kubonakale ekuhlolweni okuhlangene. Iziguli zingase futhi zibe ne-arthralgia engavamile ngaphambi kokuqala kokuvuvuka kwamalunga okubonakala ngokomtholampilo. Izimpawu zesistimu zokukhathala, ukuncipha kwesisindo, nomkhuhlane wezinga eliphansi kungase kwenzeke ngesifo esisebenzayo.
Imfuneko Yokuthola
Ku-2010, i-American College of Rheumatology kanye ne-European League Against Rheumatism babambisana ukuze benze izindlela ezintsha zokuhlukanisa i-RA (Ithebula 1) .16 Izindlela ezintsha ziwumzamo wokuxilonga i-RA ngaphambi kwesikhathi ezigulini okungenzeka zingahlangabezani nesigaba se-1987 American College of Rheumatology. imibandela. Imibandela yango-2010 ayibandakanyi ukuba khona kwamaqhuqhuva e-rheumatoid noma izinguquko zokuguguleka kwe-radiographic, kokubili okungenzeka mancane kakhulu nge-RA yakuqala. I-symmetric arthritis ayidingeki futhi kumibandela yango-2010, okuvumela ukwethulwa kwangaphambi kwesikhathi kwe-asymmetric. Ukwengeza, abacwaningi baseDashi baye bahlakulela futhi baqinisekisa umthetho wokubikezela emtholampilo we-RA (Ithebula 2) .17,18 Inhloso yalo mthetho ukusiza ukukhomba iziguli ezine-arthritis engahlukanisiwe okungenzeka ukuthi iqhubekele ku-RA, kanye nokuqondisa ukulandela- phezulu kanye nokudluliselwa.
Izivivinyo zokuxilonga
Izifo ezizimele ezifana ne-RA zivame ukubonakala ngokuba khona kwama-autoanti- body. I-Rheumatoid factor ayiqondile ku-RA futhi ingase ibe khona ezigulini ezinezinye izifo, njenge-hepatitis C, nakubantu abadala abanempilo. I-anti-citrullinated protein antibody icace kakhulu ku-RA futhi ingase ibe neqhaza ku-pathogenesis yesifo.6 Cishe amaphesenti angama-50 kuya kwangu-80 abantu abane-RA ane-rheumatoid factor, anti-citrullinated protein antibody, noma kokubili.10 Iziguli ezine-RA zingase zibe nazo. umphumela wokuhlolwa kwe-anuclear antibody, futhi ukuhlolwa kubaluleke kakhulu ezinhlotsheni zentsha zalesi sifo. Amazinga e-protein ayi-19 e-C-reactive kanye nezinga le-erythrocyte sedimentation livame ukukhuphuka nge-RA esebenzayo, futhi lawa ma-reactants esigaba esibucayi ayingxenye entsha. I-RA classification criteria.16 Amazinga amaprotheni e-C-reactive kanye ne-erythrocyte sedimentation rate ingase isetshenziselwe ukulandela umsebenzi wesifo nokusabela emithini. Isisekelo sokubala kwegazi eliphelele elinomehluko kanye nokuhlolwa kokusebenza kwezinso nesibindi kuyasiza ngoba imiphumela ingase ibe nomthelela ezinkethweni zokwelapha (isb., isiguli esinenkinga yokungasebenzi kahle kwezinso noma i-thrombocytopenia ephawulekayo cishe ngeke sinikezwe umuthi ovimbela ukuvuvukala [NSAID]). I-anemia encane yesifo esingelapheki ivela kumaphesenti angu-33 kuya kwangu-60 azo zonke iziguli ezine-RA, i-20 nakuba ukulahlekelwa kwegazi emathunjini kufanele futhi kucatshangelwe ezigulini ezithatha i-corticosteroids noma ama-NSAID. I-Methotrexate iphikisana neziguli ezinesifo se-hepatic, njenge-hepatitis C, kanye neziguli ezinokukhubazeka okuphawulekayo kwezinso.21 Ukwelashwa kwe-Biologic, njenge-TNF inhibitor, kudinga ukuhlolwa kwe-tuberculin okungalungile noma ukwelashwa kwesifo sofuba esicashile. Ukuvuselelwa kwe-Hepatitis B kungenzeka futhi ngokusetshenziswa kwe-TNF inhibitor.22 I-Radiography yezandla nezinyawo kufanele yenziwe ukuze kuhlolwe izinguquko ze-periarticular erosive, ezingase zibonise uhlobo oluncane lwe-RA olunolaka.10
Ukuxilongwa Okuhlukile
Imiphumela yesikhumba iphakamisa i-systemic lupus erythematosus, i-systemic sclerosis, noma i-psoriatic arthritis. I-Polymyalgia rheumatica kufanele icatshangelwe esigulini esikhulile esinezimpawu ngokuyinhloko ehlombe nasesinqeni, futhi isiguli kufanele sibuzwe imibuzo ehlobene ne-arteritis yesikhashana ehambisanayo. I-Chest radiography iyasiza ukuhlola i-sarcoidosis njenge-etiology ye-arthritis. Iziguli ezinezimpawu ezivuvukalayo zeqolo, umlando wesifo samathumbu avuvukalayo, noma isifo samehlo esivuvukalayo singase sibe ne-spondyloarthropathy. Abantu abanezimpawu ezingaphansi kwamasonto ayisithupha bangase babe nenqubo yegciwane, njenge-parvovirus. Iziqephu eziphindaphindayo ezizikhawulayo zokuvuvukala kwamalunga okubukhali ziphakamisa i-crystal arthropathy, futhi i-arthrocentesis kufanele yenziwe ukuze kuhlolwe amakristalu e-monosodium urate monohydrate noma i-calcium pyrophosphate dihydrate. Ukuba khona kwamaphoyinti amaningi we-myofascial trigger kanye nezimpawu ze-somatic kungase kuphakamise i-fibromyalgia, engahlala kanye ne-RA. Ukuze usize ukuqondisa ukuxilongwa nokunquma isu lokwelapha, iziguli ezine-arthritis ezivuthayo kufanele zihanjiswe ngokushesha ku-rheumatology subspecialist.16,17
I-Rheumatoid arthritis, noma i-RA, uhlobo oluvame kakhulu lwe-arthritis. I-RA yisifo esizimele, esibangelwa lapho amasosha omzimba, isimiso sokuzivikela somzimba womuntu, sihlasela amangqamuzana awo nezicubu, ikakhulukazi amalunga. I-Rheumatoid arthritis ivame ukubonakala ngezimpawu zobuhlungu nokuvuvukala, ngokuvamile ezithinta amalunga amancane ezandla, izihlakala nezinyawo. Ngokusho kochwepheshe abaningi bezokunakekelwa kwempilo, ukuhlonzwa kusenesikhathi kanye nokwelashwa kwe-RA kubalulekile ukuze kuvinjelwe ukulimala kwamalunga nokunciphisa izimpawu ezibuhlungu. UDkt. Alex Jimenez DC, CCST Insight
Ukwelashwa
Ngemva kokuba i-RA ixilongwa futhi kwenziwa ukuhlolwa kokuqala, ukwelashwa kufanele kuqale. Imihlahlandlela yakamuva ikhulume nabaphathi be-RA, i-21,22 kodwa ukukhetha kwesiguli nakho kunendima ebalulekile. Kukhona ukucatshangelwa okukhethekile kwabesifazane abaneminyaka yobudala ngoba imithi eminingi inemiphumela eyingozi ekukhulelweni. Imigomo yokwelapha ihlanganisa ukunciphisa ubuhlungu obuhlangene nokuvuvukala, ukuvimbela ukukhubazeka (okufana nokuchezuka kwe-ulnar) nokulimala kwe-radiographic (njengokuguguleka), ukugcina izinga lokuphila (okomuntu siqu kanye nomsebenzi), nokulawula ukubonakaliswa okungaphezulu kwe-articular. Imithi elwa nokuvuvukala eguqula izifo (DMARDs) iyinsika yokwelashwa kwe-RA.
Ama-DMARD
Ama-DMARD angaba yi-biologic noma i-nonbiologic (Ithebula 3) .23 Ama-Biologic agents ahlanganisa amasosha omzimba e-monoclonal kanye nama-recombinant receptors ukuze avimbele ama-cytokines akhuthaza i-cascade yokuvuvukala ebhekene nezimpawu ze-RA. I-Methotrexate inconywa njengendlela yokwelapha yokuqala ezigulini ezine-RA esebenzayo, ngaphandle uma iphikisana noma ingabekezeleleki.21 I-Leflunomide (Arava) ingasetshenziswa njengenye indlela ye-methotrexate, nakuba imiphumela emibi yamathumbu ivame kakhulu. I-Sulfasalazine (Azulfidine) noma i-hydroxychloroquine (i-Plaquenil) ebangela ukuvuvukala njenge-monotherapy ezigulini ezinomsebenzi ophansi wesifo noma ezingenazo izici zokubikezela ezimbi (isb., i-seronegative, i-RA engacelisisi).21,22 Ukwelapha okuhlanganisiwe nama-DMARD amabili noma ngaphezulu kusebenza kangcono kakhulu. ngaphandle kwe-monotherapy; kodwa-ke, imiphumela emibi ingase ibe mkhulu.24 Uma i-RA ingalawulwa kahle nge-DMARD engeyona ye-biologic, i-DMARD ye-biologic kufanele iqalwe.I-21,22 TNF inhibitors iyindlela yokwelapha ye-biologic yokuqala futhi iyona efundwa kakhulu kulawa ma-agent. Uma ama-TNF inhibitors engasebenzi, izindlela zokwelapha ezengeziwe ze-biologic zingacatshangelwa. Ukusetshenziswa kanyekanye kokwelapha okungaphezu kokukodwa kwe-biologic (isb, i-adalimumab [Humira] ne-abatacept [Orencia]) akunconywa ngenxa yezinga elingamukeleki lemiphumela emibi.21
Ama-NSAID kanye nama-Corticosteroids
Ukwelashwa ngezidakamizwa kwe-RA kungase kuhlanganise ama-NSAID kanye ne-oral, intramuscular, noma intra-articular corticosteroids yokulawula ubuhlungu nokuvuvukala. Ngokufanelekile, ama-NSAID nama-corticosteroids asetshenziselwa ukuphatha isikhathi esifushane kuphela. Ama-DMARD yindlela yokwelapha ekhethwayo.21,22
Izindlela Zokwelapha Ezihambisanayo
Ukungenelela kokudla, okuhlanganisa ukudla kwemifino kanye nokudla kwaseMedithera, kufundwe ekwelapheni i-RA ngaphandle kobufakazi obugculisayo benzuzo. nge-RA.25,26 Ngaphezu kwalokho, i-thermotherapy kanye ne-ultrasound yokwelapha ye-RA ayizange ifundwe ngokwanele.27,28 Ukubuyekezwa kwe-Cochrane yemithi yokwelapha ye-RA iphethe ngokuthi i-gamma-linolenic acid (kusukela ku-primrose kusihlwa noma amafutha e-currant emnyama) kanye ne-Tripterygium i-wilfordii (i-thunder god vine) inezinzuzo ezingase zibe khona.29,30 Kubalulekile ukwazisa iziguli ukuthi imiphumela emibi emibi iye yabikwa ngokusetshenziswa kwemithi yokwelapha.31
Ukuzivocavoca Nokwelapha Ngomzimba
Imiphumela yezilingo ezilawulwa ngokungahleliwe isekela ukuvivinya umzimba ukuze kuthuthukiswe izinga lokuphila namandla emisipha ezigulini ezine-RA.32,33 Izinhlelo zokuqeqesha umzimba azizange ziboniswe zinemiphumela eyingozi emsebenzini we-RA wesifo, amaphuzu obuhlungu, noma umonakalo ohlangene we-radiographic. I-34 i-Tai chi iboniswe ukuthuthukisa ukunyakaza kwama-ankle kubantu abane-RA, nakuba ukuhlolwa okungahleliwe kunqunyelwe.35 Izilingo ezilawulwa ngokungahleliwe ze-Iyengar yoga kubantu abasha abane-RA ziyaqhubeka.36
Isikhathi Sokwelashwa
Ukukhululwa kutholakala kumaphesenti angu-10 kuya kwangu-50 eziguli ezine-RA, kuye ngokuthi ukuxolelwa kuchazwa kanjani kanye namandla okwelapha.10 Ukukhululwa kungenzeka kakhulu kwabesilisa, abangabhemi, abantu abangaphansi kweminyaka engu-40, nakulabo abanesifo esisheshe sifike ( iziguli ezindala kuneminyaka engu-65), ezinesikhathi esifushane sesifo, esinomsebenzi wesifo esibi kakhulu, ngaphandle kwama-reactants e-acute phase ephakeme, futhi ngaphandle kwesici esihle se-rheumatoid noma okutholakala kwe-anti-citrullinated protein antibody.37 Ngemva kokulawulwa kwesifo, imithamo yemithi ingase yehliswe ngokuqapha. ngenani elincane elidingekayo. Iziguli zizodinga ukuqapha njalo ukuze kuqinisekiswe izimpawu ezizinzile, futhi ukwanda ngokushesha kwemithi kunconywa ngokuqubuka kwezifo.22
Ukujoyina Okuhlangene
Ukushintshwa kwamalunga kuboniswa uma kukhona ukulimala okukhulu kwamalunga kanye nokulawulwa okungagculisi kwezimpawu ngokuphathwa kwezokwelapha. Imiphumela yesikhathi eside iwukusekelwa, okunamaphesenti angu-4 kuya kwangu-13 kuphela okushintshaniswa okukhulu okudinga ukubuyekezwa phakathi neminyaka eyi-10 I-hip nedolo yizona ezivame ukushintshwa.
Ukuqapha Kwesikhathi Eside
Nakuba i-RA ithathwa njengesifo samalunga, iphinde ibe yisifo sesistimu esikwazi ukubandakanya izinhlelo zezitho eziningi. Ukubonakaliswa okungeziwe kwe-RA kufakwe kuThebula 4.1,2,10 Iziguli ezine-RA zinengozi ephindwe kabili eyanda ye-lymphoma, okucatshangwa ukuthi ibangelwa inqubo yokuvuvukala engaphansi, hhayi umphumela wokwelashwa.39 Iziguli ezine-lymphoma I-RA nayo isengozini eyengeziwe yokuba nesifo se-coronary artery, futhi odokotela kufanele basebenze neziguli ukuze baguqule izici eziyingozi, njengokubhema, umfutho wegazi ophakeme, kanye ne-cholesterol ephezulu.40,41 I-Class III noma i-IV congestive heart failure (CHF) ukuphikisana nokusetshenziswa kwe-TNF inhibitors, okungase kube nzima kakhulu imiphumela ye-CHF. I-Biologic DMARD, i-methotrexate, ne-leflunomide akufanele iqalwe ezigulini ezine-herpes zoster esebenzayo, ukutheleleka okuphawulekayo kwefungal, noma ukutheleleka kwebhaktheriya okudinga ama-antibiotics.21 Izinkinga ze-RA kanye nokwelashwa kwayo zibhalwe kuThebula 21
Isibikezelo
Iziguli ezine-RA ziphila iminyaka emithathu kuya kwengu-12 ngaphansi komphakathi jikelele.40 Ukufa okukhulayo kulezi ziguli kubangelwa ikakhulukazi isifo senhliziyo esisheshayo, ikakhulukazi kulabo abanomsebenzi wezifo eziphezulu kanye nokuvuvukala okungapheli. Imithi yokwelapha emisha uma kuqhathaniswa ingase ihlehlise ukuqhubeka kwesifo sokuqina kwemithambo yegazi futhi andise ukuphila kwalabo abane-RA.41
Imithombo yedatha: Ukusesha kwe-PubMed kwaqedwa kokuthi Imibuzo Yomtholampilo kusetshenziswa amagama ayinhloko i-arthritis ye-rheumatoid, ukubonakaliswa okungaphezulu kwe-articular, nama-antirheumatic agents aguqula izifo. Ukusesha kwakuhlanganisa ukuhlaziywa kwe-meta, ukuhlolwa okulawulwa ngokungahleliwe, ukuhlolwa kwemitholampilo, nokubuyekezwa. Kwaseshwa futhi i-Agency for Healthcare Research kanye nemibiko yobufakazi bekhwalithi, Ubufakazi Bemitholampilo, isizindalwazi se-Cochrane, Ubufakazi Obubalulekile, kanye ne-UpToDate. Idethi yokusesha: Septhemba 20, 2010.
Ukudalulwa kombhali: Awekho amanxusa ezezimali okufanele adalulwe. Ekuphetheni, i-rheumatoid arthritis yisifo esingapheli, esizimele esibangela izimpawu ezibuhlungu, njengobuhlungu nokungahambi kahle, ukuvuvukala nokuvuvukala kwamalunga, phakathi kwabanye. Umonakalo ohlangene obonakala ngokuthi i-RA uyalingana, okusho ukuthi ngokuvamile uthinta izinhlangothi zombili zomzimba. Ukuxilongwa kusenesikhathi kubalulekile ekwelapheni i-RA. Ububanzi bolwazi lwethu bukhawulelwe ezindabeni ze-chiropractic kanye nezempilo yomgogodla. Ukuze uxoxe ngesihloko, sicela ukhululeke ukubuza uDkt. Jimenez noma usithinte kokuthi
915-850-0900 . Ikhethwe nguDkt Alex Jimenez
Ingxoxo Yesihloko Eyengeziwe: Ukukhulula Ubuhlungu Bedolo Ngaphandle Kokuhlinzwa
Ubuhlungu bedolo kuwuphawu olwaziwayo olungase lwenzeke ngenxa yokulimala kwamadolo kanye/noma izimo, kuhlanganisa
ukulimala kwezemidlalo. Idolo lingelinye lamalungu ayinkimbinkimbi kakhulu emzimbeni womuntu njengoba lenziwe ngokuphambana kwamathambo amane, imigqa emine, imisipha ehlukahlukene, i-menisci emibili, ne-cartilage. Ngokusho kwe-American Academy of Family Physicians, izimbangela ezivame kakhulu zobuhlungu bamadolo zihlanganisa i-patellar subluxation, i-patellar tendinitis noma i-jumper's knee, nesifo sika-Osgood-Schlatter. Nakuba ubuhlungu bamadolo buvame ukwenzeka kubantu abangaphezu kweminyaka engu-60 ubudala, ubuhlungu bamadolo bungenzeka nasezinganeni nasebancane. Ubuhlungu bamadolo bungaphathwa ekhaya ngokulandela izindlela ze-RICE, noma kunjalo, ukulimala kanzima kwamadolo kungase kudinge ukunakekelwa kwezokwelapha ngokushesha, kuhlanganise nokunakekelwa kwe-chiropractic.
***